PRECONFERENCE WORKSHOP

How AI-powered pathology will usher in the new frontier of precision medicine

Join us to explore how advanced AI solutions can foreground pathology within the optimized clinical diagnostic & care pathway and support improved therapeutic decision making. We’ll also cover how breakthroughs in this space are driving the discovery and development of better targeted therapies, and how digital pathology can transform the way we conceive of and leverage biomarkers. This session will investigate recent advances in AI and digital pathology, and present compelling use cases, research, and products that are already bringing about tangible transformation for pathologists and clinicians. We’ll conclude with a panel led Q&A with the audience.

Presented by:

Sean Khozin, MD, MPH

Impact Advisor, Owkin

Senior Partner, Braven

Founder, Phyusion

Sean Khozin, MD, MPH is a board-certified oncologist, Impact Advisor at Owkin and Senior Partner at Braven. He is the former CEO of CancerLinQ, global head of data science innovation at J&J, founding Executive Director of FDA’s first data science incubator FDA INFORMED, Associate Director of FDA’s Oncology Center of Excellence, and clinical investigator at the US National Cancer Institute. Prior his tenure in federal government, he co-founded Hello Health, a pioneering TechBio company focused on advancing patients care and clinical research. Dr. Khozin is a Research Affiliate at MIT and serves on the Board of Society for Translational Oncology.

Katharina Von Loga

Head of Pathology

Owkin

Katharina Von Loga is a Clinician Scientist and Consultant Molecular Pathologist focussing on immuno-oncology research. She led a translational pathology lab at the Royal Marsden Hospital and the Institute of Cancer Research in London, UK. Her group developed computational pathology tools and multiplex staining workflows to monitor and stratify tumors with the aim of clinical integration and optimised personalised medicine. She was a member of several national Trial Management Groups and provided mentorship for medical fellows, PhD and postdoctoral students. Her peer-reviewed research revolves around the intersection of traditional histopathology, molecular pathology and artificial intelligence. Katharina is Head of Pathology at Owkin.